Edmond Karen M, Strobel Natalie A, McAuley Kimberley, Geelhoed Elizabeth, Hurt Lisa
School of Paediatrics and Child Health, The University of Western Australia, Perth, WA, Australia.
School of Paediatrics and Child Health, The University of Western Australia, 35 Stirling Highway, Crawley, WA, 6009, Australia.
Syst Rev. 2017 Mar 21;6(1):59. doi: 10.1186/s13643-017-0450-6.
Frequently cited benefit-cost ratios suggest that interventions to improve neurodevelopment have high economic returns when implemented during pregnancy and early childhood. However, there are many challenges when primary care providers implement these interventions at scale, and it is unclear how many research studies or programmes have examined cost-effectiveness and which methods were used. There are no current scoping or systematic reviews which have assessed economic evaluations of interventions delivered by primary care providers to improve child neurodevelopment.
METHODS/DESIGN: The aim of this review is to describe the economic evaluations of interventions delivered by primary care providers to improve neurodevelopment in children aged 0-4 years. Specific subgroup analyses will include income level of country (high, middle and low); population type (universal vs targeted); time period when intervention was implemented (antenatal vs infancy [0-11 months] vs early childhood [12-59 months]); and setting (research study vs programmes evaluation at scale). All study designs will be included. The primary outcomes of interest are cost per neurodevelopmental or cognitive health gain in children aged 0-4 years. All measures of cost, neurodevelopment or cognitive function that have been previously validated as an appropriate test in this domain will be included. Databases such as MEDLINE (OVID), PsycINFO (OVID), EMBASE (OVID), CINAHL, Cochrane Library (including CENTRAL, DARE, HTA and NHS EED), Paediatric Economic Database Evaluation (PEDE) and WHO databases and reference lists of papers will be searched for relevant articles. Five phases will be followed: identifying the research question, identifying relevant studies, study selection, charting data and collating, summarising and reporting results. We will present cost and effectiveness data descriptively.
This review appears to be the first to be conducted in this area. The findings will be an important resource for future systematic reviews on interventions that have a cost component. This information will be valuable for policy makers and programmers who work in public health or primary care settings.
经常被引用的效益成本比表明,在孕期和幼儿期实施改善神经发育的干预措施具有很高的经济回报率。然而,初级保健提供者大规模实施这些干预措施时存在诸多挑战,目前尚不清楚有多少研究或项目考察了成本效益以及采用了哪些方法。目前尚无针对初级保健提供者实施的改善儿童神经发育干预措施的经济评估进行的范围界定或系统评价。
方法/设计:本综述旨在描述初级保健提供者实施的改善0至4岁儿童神经发育的干预措施的经济评估。具体的亚组分析将包括国家收入水平(高、中、低);人群类型(普遍人群与目标人群);干预实施的时间段(产前、婴儿期[0至11个月]、幼儿期[12至59个月]);以及环境(研究、大规模项目评估)。将纳入所有研究设计。主要关注的结果是0至4岁儿童每获得神经发育或认知健康改善的成本。将纳入所有先前已被验证为该领域适当测试的成本、神经发育或认知功能测量指标。将检索MEDLINE(OVID)、PsycINFO(OVID)、EMBASE(OVID)、CINAHL、Cochrane图书馆(包括CENTRAL、DARE、HTA和NHS EED)、儿科经济数据库评估(PEDE)、世界卫生组织数据库等数据库以及论文的参考文献列表以查找相关文章。将遵循五个阶段:确定研究问题、识别相关研究、研究选择、绘制数据以及整理、总结和报告结果。我们将以描述性方式呈现成本和效益数据。
本综述似乎是该领域的首次研究。研究结果将成为未来对具有成本构成部分的干预措施进行系统评价的重要资源。这些信息对于在公共卫生或初级保健环境中工作的政策制定者和项目规划者将具有重要价值。